World Journal of Surgery

, Volume 34, Issue 4, pp 632–634 | Cite as

Fibrin Sealant: Past, Present, and Future: A Brief Review

Article

Abstract

Background

Fibrin sealant is a two-component topical hemostat, sealant, and tissue adhesive consisting of fibrinogen and thrombin that has been used in the United States as a blood bank- or laboratory-derived product since the 1980s and has been commercially available since 1998.

Methods/results

Initially, surgeons employed hospital-based materials because of the lack of availability of a commercially produced agent. At present, there are five U.S. Food and Drug Administration (FDA)-approved forms including products derived from pooled or autologous human plasma as well as bovine plasma. On-label indications include hemostasis, colonic sealing, and skin graft attachment. Recent clinical and experimental uses include tissue or mesh attachment, fistula closure, lymphatic sealing, adhesion prevention, drug delivery, and tissue engineering.

Conclusions

The modern literature on fibrin sealant now exceeds 3000 articles and continues to expand. This brief review presents the history of this material, its present clinical use, and its future applications.

Notes

Acknowledgment

The author thanks Dr. Eric Rose for his interest in fibrin sealant at the Columbia Presbyterian Medical Center during the1980s, which facilitated the author’s exploration of the clinical and experimental use of this material.

References

  1. 1.
    Spotnitz WD, Burks S (2008) Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 48:1502–1516CrossRefPubMedGoogle Scholar
  2. 2.
    Spotnitz WD, Prabhu R, Welker R (2004) Clinical uses of fibrin sealant. In: Mintz PD et al (eds) Transfusion therapy: clinical principles and practice, 2nd edn. AABB Press, Bethesda, MD, pp 437–477Google Scholar
  3. 3.
    Bergel S (1909) Uber wirkungen des fibrins. Dtsch Med Wochenschr 35:633CrossRefGoogle Scholar
  4. 4.
    Young JZ, Medawar PB (1940) Fibrin suture of peripheral nerves. Lancet 275:126–132CrossRefGoogle Scholar
  5. 5.
    Cronkite EP, Lozner EL, Deaver J (1944) Use of thrombin and fibrinogen in skin grafting. JAMA 124:976–978Google Scholar
  6. 6.
    Matras H, Dings HP, Manoli B et al (1972) Zur nachtlosen Interfaszikularen Nerventransplantation im Tierexperiment. Wein Med Wochenschr 122:517–523Google Scholar
  7. 7.
    Spotnitz WD, Welker R (1999) Clinical uses of fibrin sealant. In: Mintz PD (ed) Transfusion therapy: clinical principles and practice, 1st edn. AABB Press, Bethesda, MD, pp 199–222Google Scholar
  8. 8.
    Dresdale A, Rose EA, Jeevanandam V et al (1985) Preparation of fibrin glue from single-donor fresh-frozen plasma. Surgery 97:750–755PubMedGoogle Scholar
  9. 9.
    Matthew TL, Spotnitz WD, Kron IL et al (1990) Four years experience with fibrin sealant in thoracic and cardiovascular surgery. Ann Thorac Surg 50:40–44PubMedCrossRefGoogle Scholar
  10. 10.
    Siedentop KH, Harris DM, Sanchez B (1985) Autologous fibrin tissue adhesive. Laryngoscope 95:1074–1076CrossRefPubMedGoogle Scholar
  11. 11.
    Spotnitz WD, Mintz PD, Avery N et al (1987) Fibrin glue from stored human plasma: an inexpensive and efficient method for local blood bank preparation. Am Surg 53:460–464PubMedGoogle Scholar
  12. 12.
    Spotnitz WD (1995) Fibrin sealant in the United States: clinical use at the University of Virginia. Thromb Haemost 74:482–485PubMedGoogle Scholar
  13. 13.
    Spotnitz WD, Burks SG, Prabhu R (2005) Fibrin-based adhesives and hemostatic agents. In: Quinn JV (ed) Tissue adhesives in clinical medicine. BC Decker, Hamilton, Ontario, Canada, pp 77–112Google Scholar
  14. 14.
    Chung W, Kazemi P, Ko D et al (2009) Anal fistula plug and fibrin glue versus conventional treatment in repair of complex anal fistulas. Am J Surg 197:604–608CrossRefPubMedGoogle Scholar
  15. 15.
    Ruggiero R, Procaccini E, Gili S et al (2008) Fibrin glue to reduce seroma after axillary lymphadenectomy for breast cancer. Minerva Chir 63:249–254PubMedGoogle Scholar
  16. 16.
    Fortelny RH, Schwab R, Glaser KS et al (2008) The assessment of quality of life in a trial on lightweight mesh fixation with fibrin sealant in transabdominal preperitoneal hernia repair. Hernia 12:499–505CrossRefPubMedGoogle Scholar
  17. 17.
    Garcia-Olmo D, Herreros D, Pascual I et al (2009) Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 52:79–86PubMedGoogle Scholar
  18. 18.
    Zhibo X, Miaobo Z (2009) Effect of sustained-release lidocaine on reduction of pain after subpectoral breast augmentation. Aesthet Surg J 29:32–34CrossRefPubMedGoogle Scholar
  19. 19.
    Ishii I, Mizuta H, Sei A et al (2007) Healing of full-thickness defects of the articular cartilage in rabbits using fibroblast growth factor-2 and a fibrin sealant. J Bone Joint Surg Br 89:693–700CrossRefPubMedGoogle Scholar
  20. 20.
    Leong DT, Nah WK, Gupta A et al (2008) The osteogenic differentiation of adipose tissue-derived precursor cells in a 3D scaffold/matrix environment. Curr Drug Discov Technol 5:319–327CrossRefPubMedGoogle Scholar
  21. 21.
    Schillinger U, Wexel G, Hacker C et al (2009) A fibrin glue composition as carrier for nucleic acid vectors. Pharm Res 25:2946–2962CrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2009

Authors and Affiliations

  1. 1.Department of Surgery, Surgical Therapeutic Advancement CenterUniversity of Virginia Health SystemCharlottesvilleUSA

Personalised recommendations